OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Biogen/  US09062X1037  /

Cboe US
5/2/2024  9:59:52 PM Chg. -2.80 Volume Bid10:25:00 PM Ask11:08:21 PM Market Capitalization Dividend Y. P/E Ratio
213.39USD -1.30% 47,189
Turnover: 3.47 mill.		 -Bid Size: - 214.90Ask Size: 1 31.09 bill.USD - 26.62
GlobeNewswire 1:30 PM Biogen Reports Progress on Corporate Responsibility Priorities
GlobeNewswire 4/29 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...
GlobeNewswire 4/25 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
TeleTrader 4/24 US closes mixed with earnings in limelight
TeleTrader 4/24 Biogen posts Q1 revenue of $2.3 billion
TeleTrader 4/24 US mostly up premarket with earnings in focus
GlobeNewswire 4/23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
TeleTrader 4/21 Weekly Preview: Key earnings reports expected
GlobeNewswire 4/17 Unispace Group announces new EMEA CEO appointment
GlobeNewswire 4/15 Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
GlobeNewswire 4/10 Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
GlobeNewswire 4/2 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
GlobeNewswire 4/2 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 4/1 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 3/25 Dyne Therapeutics Announces CEO Transition
GlobeNewswire 3/13 Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
GlobeNewswire 3/11 Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...
GlobeNewswire 3/8 From the Beach to the Boardroom: Unispace's 'Art for Impact' Program Partners with NGO to Turn 50,00...
GlobeNewswire 3/7 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BI...
GlobeNewswire 3/6 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire 3/6 Genesis Research Group Announces Appointment of David W. Miller as CEO
GlobeNewswire 3/4 Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (...
GlobeNewswire 2/28 Promising Pathways to Simplified Alzheimer's Diagnosis Unveiled in Groundbreaking Study
GlobeNewswire 2/27 Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlig...
GlobeNewswire 2/27 Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024